Appello Pharmaceuticals Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$27M
- Investors
-
5
Appello Pharmaceuticals General Information
Description
Developer of allosteric modulators designed to help treat Parkinson's disease. The company's modulators specialize in positive allosteric and focus on identifying and developing innovative early-stage drug candidates for patients living with disorders of the nervous system, enabling pharmaceutical developers and clinical partners to address unmet needs in neurological disease and improve patient outcomes.
Contact Information
Website
www.appellopharma.comCorporate Office
- 4015 Hillsboro Pike 222
- Suite 417
- Nashville, TN 37215
- United States
Corporate Office
- 4015 Hillsboro Pike 222
- Suite 417
- Nashville, TN 37215
- United States
Appello Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 13-Nov-2024 | $27M | Completed | Clinical Trials - Phase 2 | ||
| 4. Later Stage VC (Series B) | 24-Jan-2022 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC (Series A) | 13-Nov-2020 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 25-Jun-2018 | $15.5M | $15.5M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Appello Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 3,126,893 | $0.001000 | 8% | $5 | $5 | 1x | $5 | 26.23% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Appello Pharmaceuticals Comparisons
Industry
Financing
Details
Appello Pharmaceuticals Competitors (47)
One of Appello Pharmaceuticals’s 47 competitors is XWPharma, a Venture Capital-Backed company based in Redwood City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| XWPharma | Venture Capital-Backed | Redwood City, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Angiochem | Formerly VC-backed | Westmount, Canada | ||||
| Minerva Neurosciences | Formerly VC-backed | Burlington, MA | ||||
| PAQ Therapeutics | Venture Capital-Backed | Cambridge, MA |
Appello Pharmaceuticals Signals
Appello Pharmaceuticals Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Relevance Ventures | Venture Capital | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| Mountain Group Partners | Venture Capital | Minority | ||
| Vanderbilt University | University | Minority |
Appello Pharmaceuticals FAQs
-
When was Appello Pharmaceuticals founded?
Appello Pharmaceuticals was founded in 2017.
-
Where is Appello Pharmaceuticals headquartered?
Appello Pharmaceuticals is headquartered in Nashville, TN.
-
What is the size of Appello Pharmaceuticals?
Appello Pharmaceuticals has 7 total employees.
-
What industry is Appello Pharmaceuticals in?
Appello Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Appello Pharmaceuticals a private or public company?
Appello Pharmaceuticals is a Private company.
-
What is the current valuation of Appello Pharmaceuticals?
The current valuation of Appello Pharmaceuticals is .
-
What is Appello Pharmaceuticals’s current revenue?
The current revenue for Appello Pharmaceuticals is .
-
How much funding has Appello Pharmaceuticals raised over time?
Appello Pharmaceuticals has raised $59.1M.
-
Who are Appello Pharmaceuticals’s investors?
Relevance Ventures, Alexandria Venture Investments, Deerfield Management, Mountain Group Partners, and Vanderbilt University have invested in Appello Pharmaceuticals.
-
Who are Appello Pharmaceuticals’s competitors?
XWPharma, Sangamo Therapeutics, Angiochem, Minerva Neurosciences, and PAQ Therapeutics are some of the 47 competitors of Appello Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process